Compare RAPT & EVAC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | RAPT | EVAC |
|---|---|---|
| Founded | 2015 | 2024 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Fluid Controls |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.7B | 590.3M |
| IPO Year | 2019 | N/A |
| Metric | RAPT | EVAC |
|---|---|---|
| Price | $58.00 | $10.08 |
| Analyst Decision | Buy | |
| Analyst Count | 10 | 0 |
| Target Price | ★ $56.22 | N/A |
| AVG Volume (30 Days) | ★ 4.6M | 63.9K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.71 | $9.90 |
| 52 Week High | $58.02 | $10.17 |
| Indicator | RAPT | EVAC |
|---|---|---|
| Relative Strength Index (RSI) | 78.57 | 47.59 |
| Support Level | $32.00 | $9.99 |
| Resistance Level | N/A | $10.17 |
| Average True Range (ATR) | 0.09 | 0.03 |
| MACD | -0.79 | -0.01 |
| Stochastic Oscillator | 90.91 | 25.00 |
RAPT Therapeutics Inc is a clinical-stage immunology-based biopharmaceutical company. It is focused on discovering, developing, and commercializing oral small-molecule therapies for patients with some unmet needs in oncology and inflammatory diseases. The company pipeline products include FLX475, designed to selectively inhibit the migration of immunosuppressive regulatory T cells into tumors; and RPT193, designed to selectively inhibit the migration of type 2 T helper cells into inflamed tissues.
EQV Ventures Acquisition Corp II is a blank check company.